Medtronic (FRA:2M6) Change In Receivables : €-292 Mil (TTM As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Medtronic Change In Receivables?

Medtronic's change in receivables for the quarter that ended in Jan. 2024 was €-21 Mil. It means Medtronic's Accounts Receivable increased by €21 Mil from Oct. 2023 to Jan. 2024 .

Medtronic's change in receivables for the fiscal year that ended in Apr. 2023 was €-525 Mil. It means Medtronic's Accounts Receivable increased by €525 Mil from Apr. 2022 to Apr. 2023 .

Medtronic's Accounts Receivable for the quarter that ended in Jan. 2024 was €5,479 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Medtronic's Days Sales Outstanding for the three months ended in Jan. 2024 was 67.32.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Medtronic's liquidation value for the three months ended in Jan. 2024 was €-21,279 Mil.

Medtronic Change In Receivables Historical Data

The historical data trend for Medtronic's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Change In Receivables Chart

Medtronic Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Change In Receivables

Get a 7-Day Free Trial

-517.09

1,187.72

-636.20

-441.70

-525.31

Medtronic Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Receivables	Get a 7-Day Free Trial															-57.54	-153.22	148.26	-266.11	-21.11

Medtronic Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-292 Mil.

Medtronic (FRA:2M6) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Medtronic's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	5478.624	/	7425.702	*	91
=	67.32

2. In Ben Graham's calculation of liquidation value, Medtronic's accounts receivable are only considered to be worth 75% of book value:

Medtronic's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	7638.678	-	35655.12	+	0.75 * 5478.624	+	0.5 * 5256.468
=	-21,279

Medtronic Change In Receivables Related Terms

Thank you for viewing the detailed overview of Medtronic's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Medtronic (FRA:2M6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (FRA:2M6) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

MDT:USA MDTN:Mexico 1MDT:Italy 2M6:Germany MDTC34:Brazil MDT:Austria MDT:Argentina

Address

Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2

Website

https://www.medtronic.com

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Medtronic (FRA:2M6) Headlines

No Headlines